Total Payments
$4,105
2024 Payments
$1,069
Companies
29
Transactions
87
Medicare Patients
841
Medicare Billing
$92,625
Payment Breakdown by Category
Food & Beverage$2,577 (62.8%)
Travel$1,528 (37.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,577 | 77 | 62.8% |
| Travel and Lodging | $1,528 | 10 | 37.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,168 | 7 | $0 (2022) |
| COLOPLAST CORP | $902.87 | 11 | $0 (2024) |
| Boston Scientific Corporation | $282.06 | 4 | $0 (2024) |
| ABBVIE INC. | $268.17 | 13 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $262.47 | 11 | $0 (2024) |
| Stryker Corporation | $165.20 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $134.07 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $125.38 | 4 | $0 (2024) |
| UROGEN PHARMA, INC. | $91.52 | 3 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $85.28 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,069 | 43 | Sumitomo Pharma America, Inc. ($205.60) |
| 2023 | $546.19 | 22 | AbbVie Inc. ($104.72) |
| 2022 | $2,214 | 18 | Medtronic, Inc. ($1,168) |
| 2021 | $165.20 | 1 | Stryker Corporation ($165.20) |
| 2019 | $110.68 | 3 | Boston Scientific Corporation ($54.70) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: UROLOGY | ||||||
| 12/18/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Continence Care | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Urology | ||||||
| 12/02/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Oncology | ||||||
| 11/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Urology | ||||||
| 10/17/2024 | ConvaTec Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: CONTINENCE CARE | ||||||
| 10/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $40.09 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $29.75 | General |
| 08/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: UROLOGY | ||||||
| 08/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Oncology | ||||||
| 07/24/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/24/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: UROLOGY | ||||||
| 07/16/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: BLADDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 792 | 962 | $247,965 | $86,536 |
| 2022 | 3 | 49 | 50 | $15,549 | $6,089 |
Total Patients
841
Total Services
1,012
Medicare Billing
$92,625
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 227 | 293 | $63,288 | $22,071 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 136 | $41,480 | $15,527 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $34,017 | $11,747 | 34.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 58 | $28,500 | $7,662 | 26.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 29 | 31 | $19,685 | $7,537 | 38.3% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 14 | 14 | $13,580 | $5,293 | 39.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 48 | 56 | $10,920 | $3,600 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 63 | 71 | $9,727 | $3,228 | 33.2% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 14 | 14 | $7,364 | $2,842 | 38.6% |
| 51705 | Simple change of bladder tube | Office | 2023 | 16 | 29 | $7,047 | $2,791 | 39.6% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 27 | 28 | $3,388 | $1,286 | 38.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 21 | $3,318 | $1,210 | 36.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 18 | $1,548 | $628.74 | 40.6% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 14 | 14 | $2,198 | $434.00 | 19.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 27 | 28 | $924.00 | $279.02 | 30.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 15 | $540.00 | $206.70 | 38.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 44 | 49 | $441.00 | $193.06 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $7,429 | $2,911 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 16 | $4,880 | $1,908 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $3,240 | $1,270 | 39.2% |
About Dr. Allison Sih, M.D
Dr. Allison Sih, M.D is a Urology healthcare provider based in Berkeley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1871955898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allison Sih, M.D has received a total of $4,105 in payments from pharmaceutical and medical device companies, with $1,069 received in 2024. These payments were reported across 87 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,577).
As a Medicare-enrolled provider, Sih has provided services to 841 Medicare beneficiaries, totaling 1,012 services with total Medicare billing of $92,625. Data is available for 2 years (2022–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Berkeley, CA
- Active Since 03/29/2016
- Last Updated 07/24/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1871955898
Products in Payments
- INTERSTIM (Device) $1,180
- Titan (Device) $852.97
- GEMTESA (Drug) $262.47
- TACTRA (Device) $173.53
- 1688 (Device) $165.20
- BOTOX (Biological) $146.28
- KEYTRUDA (Biological) $134.07
- ERLEADA (Drug) $125.38
- LUPRON DEPOT (Drug) $121.89
- JELMYTO (Drug) $91.52
- PROVENGE (Drug) $85.28
- PROLARIS (Device) $56.81
- AMS (Device) $54.70
- Luja Coude (Device) $49.90
- REVI (Device) $49.56
- CAMCEVI (Drug) $48.43
- XTANDI (Drug) $47.19
- XIAFLEX (Biological) $44.05
- AVEED (Biological) $41.62
- AMS 700 (Device) $34.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.